Notification of Results

RNS Number : 1834V

Futura Medical PLC

09 January 2012

 



For immediate release

9 January 2012

Futura Medical plc

("Futura" or "the Company")

Notification of Preliminary Results

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that it will issue its preliminary results for the year ended 31 December 2011 on Tuesday 13 March 2012.

A meeting for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan Communications, 107 Cheapside, London, EC2V 6DN.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Jessica Fontaine	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NORUWORRUOAARUR